Watier H - Search Results

1

Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome.

Lapillonne H, Leclerc A, Ulinski T, Balu L, Garnier A, Dereuddre-Bosquet N, Watier H, Schlageter MH, Deschênes G. Lapillonne H, et al. Among authors: watier h. Pediatr Nephrol. 2008 Aug;23(8):1251-6. doi: 10.1007/s00467-008-0793-2. Epub 2008 May 6. Pediatr Nephrol. 2008. PMID: 18458957

2

Rituximab efficiency in children with steroid-dependent nephrotic syndrome.

Sellier-Leclerc AL, Macher MA, Loirat C, Guérin V, Watier H, Peuchmaur M, Baudouin V, Deschênes G. Sellier-Leclerc AL, et al. Among authors: watier h. Pediatr Nephrol. 2010 Jun;25(6):1109-15. doi: 10.1007/s00467-010-1465-6. Epub 2010 Mar 18. Pediatr Nephrol. 2010. PMID: 20238230 Clinical Trial.

3

Rituximab-induced T cell depletion in patients with rheumatoid arthritis: association with clinical response.

Mélet J, Mulleman D, Goupille P, Ribourtout B, Watier H, Thibault G. Mélet J, et al. Among authors: watier h. Arthritis Rheum. 2013 Nov;65(11):2783-90. doi: 10.1002/art.38107. Arthritis Rheum. 2013. PMID: 23918413 Free article.

4

Pharmacokinetics of rituximab and its clinical use: thought for the best use?

Cartron G, Blasco H, Paintaud G, Watier H, Le Guellec C. Cartron G, et al. Among authors: watier h. Crit Rev Oncol Hematol. 2007 Apr;62(1):43-52. doi: 10.1016/j.critrevonc.2006.09.004. Epub 2007 Feb 6. Crit Rev Oncol Hematol. 2007. PMID: 17287129 Review.

5

Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.

Lavielle M, Mulleman D, Goupille P, Bahuaud C, Sung HC, Watier H, Thibault G. Lavielle M, et al. Among authors: watier h. Arthritis Res Ther. 2016 Oct 28;18(1):253. doi: 10.1186/s13075-016-1152-5. Arthritis Res Ther. 2016. PMID: 27793209 Free PMC article.

6

Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma.

Roguedas AM, Watier H, Paintaud G, de Muret A, Vaillant L, Machet L. Roguedas AM, et al. Among authors: watier h. Br J Dermatol. 2005 Mar;152(3):541-4. doi: 10.1111/j.1365-2133.2005.06433.x. Br J Dermatol. 2005. PMID: 15787825

7

From the bench to the bedside: ways to improve rituximab efficacy.

Cartron G, Watier H, Golay J, Solal-Celigny P. Cartron G, et al. Among authors: watier h. Blood. 2004 Nov 1;104(9):2635-42. doi: 10.1182/blood-2004-03-1110. Epub 2004 Jun 29. Blood. 2004. PMID: 15226177 Free article. Review.

8

Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.

Dall'Ozzo S, Tartas S, Paintaud G, Cartron G, Colombat P, Bardos P, Watier H, Thibault G. Dall'Ozzo S, et al. Among authors: watier h. Cancer Res. 2004 Jul 1;64(13):4664-9. doi: 10.1158/0008-5472.CAN-03-2862. Cancer Res. 2004. PMID: 15231679

9

Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20.

Daydé D, Ternant D, Ohresser M, Lerondel S, Pesnel S, Watier H, Le Pape A, Bardos P, Paintaud G, Cartron G. Daydé D, et al. Among authors: watier h. Blood. 2009 Apr 16;113(16):3765-72. doi: 10.1182/blood-2008-08-175125. Epub 2008 Nov 24. Blood. 2009. PMID: 19029438 Free article.

10

[Biomarkers and pharmacokinetic-pharmacodynamic studies of immunosuppressive agents].

Paintaud G, Bénéton M, Watier H. Paintaud G, et al. Among authors: watier h. Therapie. 2004 Mar-Apr;59(2):179-83. doi: 10.2515/therapie:2004034. Therapie. 2004. PMID: 15359609 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters